關鍵數據
1.560今開
1.570最高
11.50K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.38%換手率
1.590昨收
1.465最低
8.82K成交額
虧損本益比靜
1.37市淨率
0.00%股息率 TTM
-68.12%ROA
4.60052週最高
1.25量比
-4.97M淨利潤
3.03M總股本
-1.6136每股盈餘TTM
0.30Beta
-94.32%ROE
1.86652週最低
6.60%振幅
-4.46%毛利率
4.54M總市值
-2.78回報/風險
3.29%風險率
操作建議
Biomerica Inc當前公司基本面數據相對非常健康,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名140/199位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Biomerica Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Biomerica Inc簡介
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
公司代碼BMRA
公司Biomerica Inc
CEOIrani (Zackary S)
網址https://biomerica.com/
公司股東
常見問題
Biomerica Inc(BMRA)的當前股價是多少?
Biomerica Inc(BMRA)的當前股價是 1.50。
Biomerica Inc股票的52週最高點是多少?
Biomerica Inc股票的52週最高點是4.60。
Biomerica Inc股票的52週最低點是多少?
Biomerica Inc股票的52週最低點是1.87。
Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是多少
Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是-2.16。